Next Article in Journal
Therapeutic Inhibition of Myc in Cancer. Structural Bases and Computer-Aided Drug Discovery Approaches
Next Article in Special Issue
FKBP5 Gene Expression Predicts Antidepressant Treatment Outcome in Depression
Previous Article in Journal
NAP Family CG5017 Chaperone Pleiotropically Regulates Human AHR Target Genes Expression in Drosophila Testis
Previous Article in Special Issue
Hsp90 Heterocomplexes Regulate Steroid Hormone Receptors: From Stress Response to Psychiatric Disease
Open AccessArticle

Proteomic Studies Reveal Disrupted in Schizophrenia 1 as a Player in Both Neurodevelopment and Synaptic Function

1
CIMUS Biomedical Research Institute, University of Santiago de Compostela-IDIS, 15782 Santiago de Compostela, Spain
2
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, MD 21287, USA
3
Department of Pharmacology, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain
4
Cell Biology and Stem Cells Unit, CIC-bioGUNE, Parque Tecnologico de Bizkaia, 48160 Derio, Spain
5
Proteomics Unit, IDIS, 15706 Santiago de Compostela, Spain
6
Department of Neuropathology, Heinrich Heine University, Medical School, 40225 Düsseldorf, Germany
7
Department of Surgery and Cancer, Imperial College London, London W12 OUQ, UK
8
Department of Medical Sciences, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Int. J. Mol. Sci. 2019, 20(1), 119; https://doi.org/10.3390/ijms20010119
Received: 17 November 2018 / Revised: 21 December 2018 / Accepted: 24 December 2018 / Published: 29 December 2018
(This article belongs to the Special Issue Molecular Psychiatry)
A balanced chromosomal translocation disrupting DISC1 (Disrupted in Schizophrenia 1) gene has been linked to psychiatric diseases, such as major depression, bipolar disorder and schizophrenia. Since the discovery of this translocation, many studies have focused on understating the role of the truncated isoform of DISC1, hypothesizing that the gain of function of this protein could be behind the neurobiology of mental conditions, but not so many studies have focused in the mechanisms impaired due to its loss of function. For that reason, we performed an analysis on the cellular proteome of primary neurons in which DISC1 was knocked down with the goal of identifying relevant pathways directly affected by DISC1 loss of function. Using an unbiased proteomic approach, we found that the expression of 31 proteins related to neurodevelopment (e.g., CRMP-2, stathmin) and synaptic function (e.g., MUNC-18, NCS-1) is altered by DISC1 in primary mouse neurons. Hence, this study reinforces the idea that DISC1 is a unifying regulator of both neurodevelopment and synaptic function, thereby providing a link between these two key anatomical and cellular circuitries. View Full-Text
Keywords: DISC1; neurodevelopment; synapse; CRMP-2; proteomics DISC1; neurodevelopment; synapse; CRMP-2; proteomics
Show Figures

Figure 1

MDPI and ACS Style

Ramos, A.; Rodríguez-Seoane, C.; Rosa, I.; Gorroño-Etxebarria, I.; Alonso, J.; Veiga, S.; Korth, C.; Kypta, R.M.; García, Á.; Requena, J.R. Proteomic Studies Reveal Disrupted in Schizophrenia 1 as a Player in Both Neurodevelopment and Synaptic Function. Int. J. Mol. Sci. 2019, 20, 119.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop